生长因子-β在血管成形术后再狭窄形成中的作用及意义
郑丽丽,傅向华,闫西艴
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 郑丽丽,傅向华,闫西艴
参考文献(References)：
- 1 Massague J. The TGF-β family of growth and differentiation factor.Cell, 1987,49:437-.
- 2 Ando T, Okuda S, Tamaki K, et al. Localization of transforminggrowth factor-β and latent transforming growth factor-β binding protein inrat kidney. Kidney International, 1995,47:733-.
- 3 Maclellan WR, Brand T, Schneider MD, et al. Transforming growth factor-β1 in cardiac ontogeny and adaption. Dirc Res, 1993,73:783- 791.
- 4 Messague J. The transforming growth factor. Trends Biochem Sci,1985,10:237-240.
- 5 Hoffman BB, Sharma K, Eriksen M, et al. Transcriptional activation ofTGF-β by high glucose. J Am Soc Nephrol, 1995,6:1041-.
- 6 Casillas LF, Cheife Z, Doody J, et al. Betaglycan presents ligand to the TGF-β signaling receptor. Cell, 1993,73:1435-.
- 7 Swith JD, Bryant SR, Couper LL, et al. Soluble transforming growth factor-β type Ⅱ receptor inhibits negative remodeling, fibroblasttransdifferentiation, and intimal lesion formation but not endothelialgrowth. Circ Res, 1999,84:1212-1222.
- 8 Schulick AH, Taylor AJ, ZuO W, et al. Overexpression of transforminggrowth factor beta 1 in arterial endothlium causes hyperplasia,apoptosis and cartilaginous metaplasia. Proc Natl Acad Sci USA, 1998,95:6983-6988.
- 9 Grainger DJ, Kemp PR, Witchell CM, et al. Transforming growthfactor-β decrease the rate of proliferation of rat vascular smooth musclecells by extending the G2 phase of the cell cycle and delays the rise incyclic AMP before entry into M phase. Biochan J. 1994,299:227-235.
- 10 Stouffer GA, Owens GK. TGF-β promotes proliferation of cultured SMCvia both PDGF-AA-dependent and PDGF-AA- independent andmechanisms. J Clin Invest, 1994,93:2048-2055.
- 11 Goodman LV, Majack RA. Vascular smooth muscle cells experss disitinct transforming growth factor-β receptor phenotypes as a functionof Cell density in culture. J Biol Chem, 1989,264:5241-5244.
- 12 Clowes AW, Clowes MM, Fingerle J, et al. Regulation of smoothmuscle cell growth in injured arterials. J Cardiocasc Pharmacol, 1989,14:S12-S15.
- 13 O'Brien ER, Alpers CE, Stewart DK, et al. Proliferation in primaryand restenotic coronary atherectomy tissue. Implications forantiproliferative therapy. Circ Res, 1993,73:223-231.
- 14 Nakajima H, Nakajima HO, Salcher O, et al. Atrial but not venticular fibrosis in mice expressing a mutant transforming growth factor-βtransgene in the heart. Circ Res, 2000,17:571-579.
- 15 Ziyadeh FN, Han DC, Cohen JA, et al. Glycated albumin stimulatesfibronetic gene expression in glomerular mesangial cells: involvement ofthe transforming growth factor-β system. Kidney International, 1998,52:631-.
- 16 Vaughan DE. AT1 receptor blockade and atherosclerosis hopeful insights into vascular protection. Circulation, 2000,102:1496-l497.
- 17 Wilson DP, Saward L, Zahradka P, et al. Angiotensin Ⅱreceptor antagonists prevent neointimal proliferation in a porine coronary artery organ culture model. Cardiovasc Res, 1999,42:761-772.
- 18 Kagami S, Border WA, Miller DE, et al. Angiotensin Ⅱstimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest, 1994,93:2431-.
- 19 Cambell SE, Katwa LC. Angiotensin Ⅱ stimulated expression of transforming growth factor beta-1 in cardiac fibroblasts andmyofibroblasts. J Moll Cell Cardiol, 1997,29:1947-1958.
- 20 Bray P, Agrotis A, Bobik A. Transforming growth factor- beta and receptor tyrodine- avtivating growth factors negatively regulate collagen genes in smooth muscle of hypertensive rats. Hypertension, 1998,31:986-994.